Cargando…

Pulmonary vascular system: A vulnerable target for COVID‐19

The number of coronavirus disease 2019 (COVID‐19) cases has been increasing significantly, and the disease has evolved into a global pandemic, posing an unprecedented challenge to the healthcare community. Angiotensin‐converting enzyme 2, the binding and entry receptor of severe acute respiratory sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ai, Jiayuan, Hong, Weiqi, Wu, Min, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662299/ https://www.ncbi.nlm.nih.gov/pubmed/34909758 http://dx.doi.org/10.1002/mco2.94

Ejemplares similares

Histamine and histamine receptor H1 (HRH1) axis: new target for enhancing immunotherapy response
por: Bai, Ziyi, et al.
Publicado: (2022)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022)

The challenges of COVID‐19 Delta variant: Prevention and vaccine development
por: He, Xuemei, et al.
Publicado: (2021)

Targeting ferroptosis as a vulnerability in pulmonary diseases
por: Yang, Li, et al.
Publicado: (2022)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021)

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
por: Tang, Fan, et al.
Publicado: (2020)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes
por: Cheng, Zesheng, et al.
Publicado: (2022)

Aging in COVID-19: Vulnerability, immunity and intervention
por: Chen, Yiyin, et al.
Publicado: (2021)

Calling for a united action to defeat COVID-19
por: Overby, Madison, et al.
Publicado: (2020)

Pulmonary Vascular Manifestations of COVID-19 Pneumonia
por: Lang, Min, et al.
Publicado: (2020)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023)

COVID-19 and the pulmonary vascular injury
por: Dai, Hai-Long, et al.
Publicado: (2020)

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development
por: Hong, Qiaonan, et al.
Publicado: (2023)

Vascular underpinning of COVID-19
por: Wazny, Vanessa, et al.
Publicado: (2020)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
por: Sakao, Seiichiro, et al.
Publicado: (2014)

Effects of Intermittent Hypoxia on Pulmonary Vascular and Systemic Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
por: Que, Haiying, et al.
Publicado: (2022)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

COVID-19 and the Vulnerable
por: Maykrantz, Sherry A., et al.
Publicado: (2020)

Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
por: De Cobelli, Francesco, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling
por: Fang, Qin, et al.
Publicado: (2023)

Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
por: Zha, Duoduo, et al.
Publicado: (2022)

COVID-19 transmission, vulnerability, persistence and nanotherapy: a review
por: Khan, Afzal Husain, et al.
Publicado: (2021)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
por: Wei, Yufeng, et al.
Publicado: (2020)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

The Enigmatic COVID-19 Vulnerabilities and the Invaluable Artificial Intelligence (AI)
por: Lainjo, Bongs
Publicado: (2021)

Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
por: Zhang, Zhe, et al.
Publicado: (2023)

Ferroptosis: A potential target of macrophages in plaque vulnerability
por: Li, Yu, et al.
Publicado: (2023)

Targeting TGF-β signal transduction for fibrosis and cancer therapy
por: Peng, Dandan, et al.
Publicado: (2022)

Pervasive systemic drivers underpin COVID-19 vulnerabilities in migrants
por: Mukumbang, Ferdinand C
Publicado: (2021)

Patterns of thromboembolic pulmonary vascular disease in COVID-19
por: Shahin, Yousef, et al.
Publicado: (2021)

Elderly African Americans: The vulnerable of the vulnerable in the COVID‐19 era
por: Bhandari, Sanjay, et al.
Publicado: (2020)

Regarding “Pulmonary Vascular Manifestations of COVID-19 Pneumonia”
por: Balestrieri, Antonella
Publicado: (2020)

Impact of COVID-19 pneumonia on pulmonary vascular volume
por: Fahrni, Guillaume, et al.
Publicado: (2023)

mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
por: Babicheva, Aleksandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7uf3dfgbodt627llgcq5iqho21